Results 301 to 310 of about 101,529 (354)

Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson's disease.

Experimental Neurology, 2016
G. Mulas, E. Espa, S. Fenu, S. Spiga, G. Cossu, Elisabetta Pillai, E. Carboni, G. Simbula, Dragana Jadzic, F. Angius, Stefano Spolitu, B. Batetta, D. Lecca, A. Giuffrida, A. Carta   +14 more
semanticscholar   +1 more source

DOPA IN PARKINSON'S DISEASE

The Lancet, 1969
openaire   +3 more sources

Dopa-responsive dystonia—clinical and genetic heterogeneity

Nature Reviews Neurology, 2015
Subhashie Wijemanne, J. Jankovic
semanticscholar   +1 more source

Switch of Surface Adhesion to Cohesion by Dopa-Fe3+ Complexation, in Response to Microenvironment at the Mussel Plaque/Substrate Interface

, 2016
Byeongseon Yang, Chanoong Lim, D. Hwang, H. Cha   +3 more
semanticscholar   +1 more source

Modification of Parkinsonism--chronic treatment with L-dopa.

New England Journal of Medicine, 1969
G. C. Cotzias, P. Papavasiliou, R. Gellene   +2 more
semanticscholar   +1 more source

Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease.

Neuroscience and Biobehavioral Reviews, 2006
R. Cools
semanticscholar   +1 more source

Metabolism of Dopa in Parkinsonism

New England Journal of Medicine, 1968
M J, Arras, G W, Bailey
openaire   +2 more sources

Targeting β-arrestin2 in the treatment of l-DOPA–induced dyskinesia in Parkinson’s disease

Proceedings of the National Academy of Sciences of the United States of America, 2015
N. Urs, Simone Bido, S. Peterson, T. Daigle, C. Bass, R. Gainetdinov, E. Bézard, M. Caron   +7 more
semanticscholar   +1 more source

DOPA AND HUNTINGTON'S DISEASE

The Lancet, 1973
openaire   +2 more sources

Four pioneers of L‐dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr

Movement Disorders, 2015
A. Lees, E. Tolosa, C. Olanow
semanticscholar   +1 more source